Skip to main content
. 2024 Jul 23;6(11):101169. doi: 10.1016/j.jhepr.2024.101169

Fig. 3.

Fig. 3

Scatterplot of the LiverRisk score and LSM in (A) cohort I and (B) cohort II focusing on the distribution of disease etiologies (colored groups) and agreement/concordance for cACLD (cut-off ≥10 kPa/points).

ALD, alcohol-related liver disease; cACLD, compensated advanced chronic liver disease; LSM, liver stiffness measurement; MASLD, metabolic dysfunction-associated steatotic liver disease.